Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.32 USD | +0.33% | +6.41% | -32.50% |
04-29 | Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating | MT |
04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.50% | 2.23B | |
-18.48% | 11.03B | |
+53.87% | 3.5B | |
-14.31% | 2.16B | |
-26.79% | 1.54B | |
+31.83% | 1.12B | |
-3.28% | 737M | |
-23.33% | 477M | |
-41.94% | 411M | |
+17.30% | 342M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health : Commences Study to Evaluate Ability of Reveal Liquid Biopsy Test to Predict Cancer Recurrence